ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $353,000 | +606.0% | 58,530 | +388.3% | 0.00% | – |
Q1 2017 | $50,000 | -21.9% | 11,987 | -22.8% | 0.00% | – |
Q4 2016 | $64,000 | -97.3% | 15,525 | -94.7% | 0.00% | -100.0% |
Q3 2016 | $2,380,000 | +9.7% | 293,842 | +5.6% | 0.01% | 0.0% |
Q2 2016 | $2,170,000 | -14.6% | 278,221 | -15.4% | 0.01% | -12.5% |
Q1 2016 | $2,540,000 | -43.4% | 329,041 | -20.9% | 0.01% | -38.5% |
Q4 2015 | $4,487,000 | +2.4% | 415,839 | -34.4% | 0.01% | 0.0% |
Q3 2015 | $4,381,000 | +43.8% | 633,998 | +84.3% | 0.01% | +62.5% |
Q2 2015 | $3,047,000 | +342.9% | 343,932 | +392.4% | 0.01% | +300.0% |
Q1 2015 | $688,000 | -83.1% | 69,842 | -79.0% | 0.00% | -80.0% |
Q4 2014 | $4,080,000 | +59.3% | 333,081 | +29.8% | 0.01% | +66.7% |
Q3 2014 | $2,561,000 | +7660.6% | 256,636 | +2462.5% | 0.01% | – |
Q1 2014 | $33,000 | -10.8% | 10,015 | -10.9% | 0.00% | – |
Q4 2013 | $37,000 | -96.7% | 11,237 | -97.0% | 0.00% | -100.0% |
Q3 2013 | $1,117,000 | -72.7% | 369,813 | -25.9% | 0.00% | -76.5% |
Q2 2013 | $4,085,000 | – | 499,404 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |